| Entry |
|
|---|
| Name |
Darifenacin (USAN/INN) |
|---|
| Formula |
C28H30N2O2
|
|---|
| Exact mass |
426.2307
|
|---|
| Mol weight |
426.55
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Product (DG00482): | D01699<US> |
|
|---|
| Efficacy |
Overactive bladder agent, Muscarinic acetylcholine receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576], CYP2D6 [HSA: 1565]
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BD Drugs for urinary frequency and incontinence
G04BD10 Darifenacin
D03654 Darifenacin (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG00482 Darifenacin
D03654 Darifenacin
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00482 Darifenacin
D03654 Darifenacin
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00482 Darifenacin
D03654 Darifenacin
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM3
D03654 Darifenacin (USAN/INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03654
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG00482 Darifenacin
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG00482 Darifenacin
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00482 Darifenacin
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 32
1 C1x C 25.0600 -22.1200
2 C1x C 26.4600 -22.1200
3 C1y C 26.8926 -20.7885
4 C1x C 25.7600 -19.9656
5 N1y N 24.6274 -20.7885
6 C1b C 23.4276 -20.0900
7 C1b C 22.2151 -20.7900
8 C8y C 21.0027 -20.0900
9 C8x C 19.7903 -20.7900
10 C8y C 18.5778 -20.0900
11 C1d C 28.0924 -20.0900
12 C8y C 29.3049 -20.7900
13 C8y C 28.0899 -18.6901
14 C8x C 29.2861 -17.9965
15 C8x C 29.2835 -16.5965
16 C8x C 28.0697 -15.8988
17 C8x C 26.8735 -16.5924
18 C8x C 26.8761 -17.9924
19 C8x C 29.3049 -22.1900
20 C8x C 30.5173 -22.8900
21 C8x C 31.7297 -22.1900
22 C8x C 31.7297 -20.7900
23 C8x C 30.5173 -20.0900
24 C8x C 21.0027 -18.6900
25 C8x C 19.7903 -17.9900
26 C8y C 18.5778 -18.6900
27 O2x O 17.2463 -18.2574
28 C1x C 16.4234 -19.3900
29 C1x C 17.2463 -20.5226
30 C5a C 31.1249 -18.4800
31 O5a O 32.3296 -19.2341
32 N1a N 31.1747 -17.0802
BOND 36
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 5 6 1
7 6 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 3 11 1 #Down
12 11 12 1
13 11 13 1
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 17 18 1
19 13 18 2
20 12 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 12 23 1
26 8 24 1
27 24 25 2
28 25 26 1
29 26 10 2
30 26 27 1
31 27 28 1
32 28 29 1
33 10 29 1
34 11 30 1
35 30 31 2
36 30 32 1
|
|---|
